Experts seek penalties for manufacturers of poor maternal medicines

Good regulatory mechanisms with penalties should be put in place to curb the circulation of substandard medicines

Stakeholders in the public and private health sectors have advocated stiffer penalties for manufacturers and distributors of poor-quality maternal medicines in the country. They made the call in Abuja at a programme on leveraging public-private partnerships (PPP) to improve access to quality mate

```

Members Only

Login or create an account to continue

This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.

New to BusinessDay? Register now and start reading.

```